Efficacy and safety of first-line PD-1/PD-L1 inhibitor combinations for extensive-stage small-cell lung cancer: a Bayesian network meta-analysis

Efficacy and safety of first-line PD-1/PD-L1 inhibitor combinations for extensive-stage small-cell lung cancer: a Bayesian network meta-analysis

Objectives: Several randomized controlled trials (RCTs) indicated that first-line programmed cell death protein-1/death-ligand 1 inhibitors plus chemotherapy (PD-1/PD-L1 + chemo) led to survival benefits in extensive-stage small-cell lung cancer (ES-SCLC) compared with platinum-based chemotherapy. T...

Full description

Bibliographic Details
Main Authors: Huijuan Li, Hedong Han, Chuling Li, Ranpu Wu, Zhaofeng Wang, Yimin Wang, Ping Zhan, Tangfeng Lv, Fang Zhang, Yong Song, Hongbing Liu
Format: Article
Language:English
Published: SAGE Publishing 2023-10-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/17588359231189430

Internet

https://doi.org/10.1177/17588359231189430

Similar Items